# ARS PHARMACEUTICALS INC (SPRY) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 82835W108
Page URL: https://superinvestorclub.com/stock/SPRY
Last updated: 2026-07-08T12:46:50.914Z

## Summary

As of the most recent 13F filing period, ARS PHARMACEUTICALS INC (SPRY) is held by 1 tracked superinvestors with an aggregate position value of $8.0M representing 01000000 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Daniel Loeb](https://superinvestorclub.com/manager/9) | Third Point | 1000000 | $8.0M | 0.39% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2024-09-30: 1 holders, $7.8M aggregate, 0536900 shares
- 2025-12-31: 1 holders, $6.5M aggregate, 0556237 shares
- 2026-03-31: 1 holders, $8.0M aggregate, 01000000 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "ARS PHARMACEUTICALS INC (SPRY) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/SPRY), aggregating SEC 13F, Form 4, and congressional disclosures."